Report #2845008

Received Jun 14, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 60 yrs
State: AZ
Recovered: Unknown
Vaccinated: Jun 13, 2025
Onset: Jun 13, 2025
Days to onset: 0
Hospital days: —

Vaccines (2)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RSV	RSV (AREXVY)	GLAXOSMITHKLINE BIOLOGICALS	1	2FP37	IM / RA
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	2	75D3A	IM / LA

Symptoms (5)

DiarrhoeaHeadacheMalaiseNauseaVomiting

Symptom narrative

PATIENT, A 60 YEAR OLD FEMALE RECEIVED HER AREXVY AND 2ND DOSE OF SHINGRIX VACCINE ON 6/13/2025 AT 12:33 PM. SHE CALLED ON 6/14/2025 AT AROUND 12:15 PM AND STATED 4 HOURS AFTER RECEIVNG AREXVY VACCINE AND 2ND DOSE OF SHINGRIX VACCINE SHE STARTED HAVING SYMPTOMS OF NAUSEA, HEADACHE, VOMITING, AND DIARRHEA. PATIENT STATED SHE CANNOT TOLERATE EATING ANYTHING AND IS UNABLE TO TAKE HER CURRENT MAINTENANCE MEDICATIONS DUE TO NOT FEELING WELL. THE CALL WITH THE PATIENT GOT DISCONNECTED WHILE SHE WAS SPEAKING TO ME. PHARMACY MANAGER ATTEMPTED TO CALL HER BACK AND LEFT VOICE MAIL ON 6/14/2025 AT 12:21 PM.

Current illness

NONE

Medical history

PATIENT STATED VERBALLY SHE HAS COPD, DIABETES WHICH IS WHY SHE WAS QUALIFIED TO RECEIVE AREXVY VACCINE AT AGE 60 YEARS.

Other medications

NONE

Allergies

PENICILLIAMINE, SULFACETAMIDE, TRAMADOL

Lab data

NONE